24-Hour, Full-Genome Scans


[Editor's note: We asked a group of Xconomists to answer the following question: "If you could patent one thing, what would it be?"]

A DNA sequencing technology that results in full genome scans in less than 24 hours. This would enable real-time profiling of cancer patients, which would be of tremendous value in determining the best treatment approach for an individual patient as well as, their likely response to certain therapies.

N. Anthony Coles is the President, Chief Executive Officer, and a member of its board of directors of Onyx Pharmaceuticals. Follow @

By posting a comment, you agree to our terms and conditions.